Ewa Dłuska

Prof. Ewa Dłuska

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Experimental Thermal and Fluid Science
Verified
Journal Article
Closed access
EDEwa Dłuska
Ewa Dłuska
SWS. Wroński
S. Wroński
TRT. Ryszczuk
T. Ryszczuk

1 February 2001 in Chemical Engineering Science
Verified
Journal Article
Closed access
EDEwa Dłuska
Ewa Dłuska
SWS Wroński
S Wroński
RHR Hubacz
R Hubacz

1 May 2009 in Desalination
Verified
Journal Article
Closed access
GZGrażyna Zakrzewska-Trznadel
Grażyna Zakrzewska-Trznadel
MHMarian Harasimowicz
Marian Harasimowicz
AMAgnieszka Miśkiewicz
Agnieszka Miśkiewicz
AJAgnieszka Jaworska
Agnieszka Jaworska
EDEwa Dłuska
Ewa Dłuska
SWStanisław Wroński
Stanisław Wroński

18 August 2017 in Nanomedicine
Verified
Journal Article
Closed access
EDEwa Dłuska
Ewa Dłuska
AMAgnieszka Krystyna Markowska-Radomska
Agnieszka Krystyna Markowska-Radomska
AMAgata Metera
Agata Metera
BTBarbara Tudek
Barbara Tudek
KKKonrad Kosicki
Konrad Kosicki
Aim: Developing pH-responsive multiple emulsion platforms for effective glioblastoma multiforme therapy with reduced toxicity, a drug release study and modeling. Materials & methods: Cancer cell line: U87 MG, multiple emulsions with pH-responsive biopolymer and encapsulated doxorubicin (DOX); preparation of multiple emulsions in a Couette–Taylor flow biocontactor, in vitro release study of DOX (fluorescence intensity analysis), in vitro cytotoxicity study (alamarBlue cell viability assay) and numerical simulation of DOX release rates. Results: The multiple emulsions offered a high DOX encapsulation efficiency (97.4 ± 1%) and pH modulated release rates of a drug. Multiple emulsions with a low concentration of DOX (0.02 μM) exhibited broadly advanced cell (U87 MG) cytotoxicity than free DOX solution used at the same concentration. Conclusion: Emulsion platforms could be explored for potential delivery of chemotherapeutics in glioblastoma multiforme therapy.

23 December 2009 in Chemical Engineering & Technology
Verified
Journal Article
Closed access
PDF file
EDEwa Dłuska
Ewa Dłuska
AMAgnieszka Krystyna Markowska-Radomska
Agnieszka Krystyna Markowska-Radomska

1 January 2009 in Chemical Engineering and Processing - Process Intensification
Verified
Journal Article
Closed access
EDEwa Dłuska
Ewa Dłuska
AMAgnieszka Krystyna Markowska-Radomska
Agnieszka Krystyna Markowska-Radomska